JESSICA KEEL: Open Payments
NPI 1730599812 · LAWRENCEVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$606 in 34 payments from 8 companies in 2025. Trend: 2023 $590 · 2024 $728 · 2025 $606
Food & beverage: $606
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $174 |
| GENZYME CORPORATION | 7 | $129 |
| GlaxoSmithKline, LLC. | 6 | $102 |
| Hikma Pharmaceuticals USA | 6 | $90 |
| Medtronic, Inc. | 1 | $60 |
| Amgen Inc. | 1 | $19 |
| Optinose US, Inc. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: DUPIXENT, NUCALA, Ryaltris, SONICISION, TEZSPIRE, Xhance.
Industry payments across NJ — which companies pay providers there.
